Kitty Rajagopalan

Kitty Rajagopalan is an experienced leader in health economics and market access, currently serving as Chief Executive Officer and President & Chief Scientific Officer at Anlitiks Inc. since January 2021. Prior to this role, Kitty held the position of Global Head & Vice President, Health Economics & Outcomes Research at Sunovion Pharmaceuticals Inc., where notable achievements included increasing budget allocations from $0 to over $20 million within four years. Kitty also served as Head of Global Health Outcomes, Pricing & Economics at Biogen Idec, focusing on strategic functions and operational frameworks across various therapeutic areas. Kitty holds a PhD and MS in Pharmaceutical Sciences with a specialization in Health Outcomes Research from West Virginia University.